Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study

Guy-Marino Hinnouho,Sébastien Czernichow,Aline Dugravot,Hermann Nabi,Eric J. Brunner,Mika Kivimaki,Archana Singh-Manoux
DOI: https://doi.org/10.1093/eurheartj/ehu123
IF: 39.3
2014-03-26
European Heart Journal
Abstract:AIM: The metabolically healthy obese (MHO) phenotype refers to obese individuals with a favourable metabolic profile. Its prognostic value is unclear and may depend on the health outcome being examined. We examined the association of MHO phenotype with incident cardiovascular disease (CVD) and type 2 diabetes.METHODS AND RESULTS: Body mass index and metabolic health, assessed using the Adult Treatment Panel-III (ATP-III) criteria, were assessed on 7122 participants (69.7% men) from the Whitehall II study, aged 39-63 years in 1991-93. Incident CVD (coronary heart disease or stroke) and type 2 diabetes were ascertained from medical screenings (every 5 years), hospital data, and registry linkage until 2009. A total of 657 individuals (9.2% of the cohort) were obese and 42.5% of these were classified as MHO in 1991-93. Over the median follow-up of 17.4 years, there were 828 incident cases of CVD and 798 incident cases of type 2 diabetes. Compared with metabolically healthy normal weight individuals, MHO subjects were at increased risk for CVD (HR = 1.97, 95% CI: 1.38-2.80) and type 2 diabetes (3.25, 95% CI: 2.32-4.54). There was excess risk in metabolically unhealthy obese compared with MHO for type 2 diabetes (1.98, 95% CI: 1.39-2.83) but not CVD (1.23, 95% CI: 0.81-1.87). Treating all measures as time varying covariates produced similar findings.CONCLUSION: For type 2 diabetes, the MHO phenotype is associated with lower risk than the metabolically unhealthy obese, but for CVD the risk is as elevated in both obesity phenotypes.
cardiac & cardiovascular systems
What problem does this paper attempt to address?
This paper aims to explore the relationship between the metabolically healthy obese (MHO) phenotype and the risks of cardiovascular disease (CVD) and type 2 diabetes. Specifically, researchers hope to analyze whether the MHO phenotype can reduce the risks of these health problems, especially when compared with metabolically unhealthy obese individuals. In addition, the study also explores the impact of body weight categories in different metabolic states on the risks of these diseases. ### Research Background Obesity and metabolic syndrome are major global public health problems, often co - exist, and define a class of "high - risk" obese individuals. However, recent studies have shown that some obese individuals, despite being overweight, have a lower burden of metabolic abnormalities and are known as the "metabolically healthy obese" (MHO) phenotype. Specific characteristics of this phenotype include high insulin sensitivity, low prevalence of hypertension, and good fasting blood glucose, blood lipid, and inflammation indicators. ### Research Objectives 1. **Evaluate the association between the MHO phenotype and the incidences of cardiovascular disease and type 2 diabetes**. 2. **Compare the differences in the risks of cardiovascular disease and type 2 diabetes between the MHO phenotype and metabolically unhealthy obese individuals**. 3. **Explore the impact of metabolic health status on the disease risks of individuals in different body weight categories**. ### Methods - **Study Population**: Data were from the Whitehall II cohort study, with a total of 7,122 participants (69.7% male), aged between 39 and 63 years. - **Metabolic Health Assessment**: The Adult Treatment Panel III (ATP - III) criteria were used to assess metabolic health. - **Follow - up Time**: The median follow - up time was 17.4 years. - **Outcome Events**: The occurrences of cardiovascular disease and type 2 diabetes were determined through medical screenings, hospital data, and registry links. ### Main Findings - **Compared with metabolically healthy normal - weight individuals, MHO individuals**: - Had an increased risk of cardiovascular disease (HR = 1.97, 95% CI: 1.38–2.80). - Had a significantly increased risk of type 2 diabetes (HR = 3.25, 95% CI: 2.32–4.54). - **Compared with MHO individuals, metabolically unhealthy obese individuals**: - Had a higher risk of type 2 diabetes (HR = 1.98, 95% CI: 1.39–2.83). - Had no significant difference in the risk of cardiovascular disease (HR = 1.23, 95% CI: 0.81–1.87). ### Conclusions - For type 2 diabetes, the risk of the MHO phenotype is lower than that of metabolically unhealthy obese individuals. - For cardiovascular disease, regardless of metabolic health status, obese individuals have a higher risk. ### Significance This study emphasizes the importance of metabolic health status in assessing the risks of cardiovascular disease and type 2 diabetes in obese individuals. Although the MHO phenotype shows a certain protective effect in terms of type 2 diabetes, obesity itself remains an important risk factor for cardiovascular disease. These findings contribute to a better understanding of the complex relationship between obesity and metabolic health and provide a scientific basis for public health policy - making.